Literature DB >> 24534412

Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence.

Martine Wallon1, Justus G Garweg, Michal Abrahamowicz, Catherine Cornu, Sandrine Vinault, Catherine Quantin, Claire Bonithon-Kopp, Stéphane Picot, François Peyron, Christine Binquet.   

Abstract

BACKGROUND: Congenital toxoplasmosis (CT) can elicit severe damage to several organs, especially the eye, and may be manifested at birth or later. We assessed the long-term ocular prognosis in a cohort of congenitally infected children treated according to a standardized protocol and monitored for up to 22 years.
METHODS: This prospective study included confirmed cases of CT, which were identified by obligatory antenatal screening at the Lyon (France) reference center between 1987 and 2008. Data obtained through ocular examinations were recorded on a standardized form and confirmed by an independent external committee. Risk factors for retinochoroiditis were identified by using a multivariable Cox model and a flexible model that accounted for changes in the factor effects during follow-up.
RESULTS: A total of 477 of 485 infected live-born children were followed for a median of 10.5 years (75th percentile: 15.0 years). During the follow-up, 142 patients (29.8%) manifested at least 1 ocular lesion. Lesions were unilateral in 98 individuals (69.0%) and caused no vision loss in 80.6%. Lesions were first manifested at a median age of 3.1 (0.0-20.7) years. In 48 (33.8%) of the children, recurrences or new ocular lesions occurred up to 12 years after the appearance of the first lesion. Early maternal infection and confirmation of CT in children, prematurity, and nonocular CT lesions at baseline were associated with a higher risk of retinochoroiditis.
CONCLUSIONS: Although the consequences of CT are rarely severe in treated children, regular postnatal monitoring is nevertheless justified because of the lifelong persisting risk of new ocular manifestations.

Entities:  

Keywords:  burden of disease; congenital toxoplasmosis; long-term prognosis; ocular lesions; retinochoroiditis

Mesh:

Year:  2014        PMID: 24534412     DOI: 10.1542/peds.2013-2153

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Use of IgG in oral fluid to monitor infants with suspected congenital toxoplasmosis.

Authors:  Emmanuelle Chapey; Valeria Meroni; François Kieffer; Lina Bollani; René Ecochard; Patricia Garcia; Martine Wallon; François Peyron
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

2.  Prematurity and Low Birth Weight did not Correlate with Anti-Toxoplasma gondii Maternal Serum Profiles--a Brazilian Report.

Authors:  Mariana Machado Lemos Fochi; Sabrina Baring; Lígia Cosentino Junqueira Franco Spegiorin; Denise Cristina Mós Vaz-Oliani; Eloisa Aparecida Galão; Antonio Hélio Oliani; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  PLoS One       Date:  2015-07-20       Impact factor: 3.240

3.  Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches.

Authors:  Francois Peyron; Rima Mc Leod; Daniel Ajzenberg; Despina Contopoulos-Ioannidis; François Kieffer; Laurent Mandelbrot; L David Sibley; Hervé Pelloux; Isabelle Villena; Martine Wallon; Jose G Montoya
Journal:  PLoS Negl Trop Dis       Date:  2017-02-16

4.  The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.

Authors:  Christine Binquet; Catherine Lejeune; Valérie Seror; François Peyron; Anne-Claire Bertaux; Olivier Scemama; Catherine Quantin; Sophie Béjean; Eileen Stillwaggon; Martine Wallon
Journal:  PLoS One       Date:  2019-09-18       Impact factor: 3.240

5.  Testing New Peptides From Toxoplasma gondii SAG1, GRA6, and GRA7 for Serotyping: Better Definition Using GRA6 in Mother/Newborns Pairs With Risk of Congenital Transmission in Mexico.

Authors:  Lizbeth Xicoténcatl-García; Sergio Enriquez-Flores; Dolores Correa
Journal:  Front Cell Infect Microbiol       Date:  2019-10-23       Impact factor: 5.293

6.  Transient mydriasis in toxoplasmosis retinochoroiditis.

Authors:  Bilal Rana; David M Hinkle
Journal:  Am J Ophthalmol Case Rep       Date:  2020-04-09

7.  Serological diagnosis of Toxoplasma gondii: analysis of false-positive IgG results and implications.

Authors:  Loïc Simon; Judith Fillaux; Aurélie Guigon; Rose-Anne Lavergne; Odile Villard; Isabelle Villena; Pierre Marty; Christelle Pomares
Journal:  Parasite       Date:  2020-02-07       Impact factor: 3.000

Review 8.  Safety and efficacy of different antibiotic regimens in patients with ocular toxoplasmosis: systematic review and meta-analysis.

Authors:  John E Feliciano-Alfonso; Juliana Muñoz-Ortiz; María Alejandra Marín-Noriega; Andrés Vargas-Villanueva; Laura Triviño-Blanco; Natalia Carvajal-Saiz; Alejandra de-la-Torre
Journal:  Syst Rev       Date:  2021-07-19

9.  A Brazilian report using serological and molecular diagnosis to monitoring acute ocular toxoplasmosis.

Authors:  Mariana Previato; Fábio Batista Frederico; Fernando Henrique Antunes Murata; Rubens Camargo Siqueira; Amanda Pires Barbosa; Aparecida Perpétuo Silveira-Carvalho; Cristina da Silva Meira; Vera Lúcia Pereira-Chioccola; Ricardo Gava; Plínio Pereira Martins Neto; Luiz Carlos de Mattos; Cinara Cássia Brandão de Mattos
Journal:  BMC Res Notes       Date:  2015-12-07

10.  Congenital Toxoplasmosis: A Plea for a Neglected Disease.

Authors:  Martine Wallon; François Peyron
Journal:  Pathogens       Date:  2018-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.